Temporal Evolution of Pulmonary Abnormalities in COVID-19 Infection: Chest CT Findings at Different Stages of Illness
International Journal of Current Pharmaceutical Review and Research · 13.05.2026 · 18 (05)
DOI: 10.25258/ijcpr.18.5.28 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Current Pharmaceutical Review and Research, online erschienen am 13.05.2026. Verfasst von Samarjeet Singh und 3 weiteren Autor:innen.
Abstract (Originalsprache)
Purpose
To characterize the spectrum and temporal evolution of chest CT findings in patients with COVID-19 pneumonia across four defined stages of illness. Materials and Methods: In this single-institution retrospective study, 105 consecutive patients with laboratoryconfirmed SARS-CoV-2 infection who underwent non-contrast chest CT from May 2020 to February 2021 were enrolled. Patients were stratified by interval from symptom onset to CT scan into five groups: early (0–4 days; n=28), progressive (5–8 days; n=28), peak (9–13 days; n=23), late (14–30 days; n=17), and delayed (>30 days; n=9). CT images were evaluated for 17 distinct findings using standard Fleischner Society nomenclature. Disease burden was quantified using a validated 25-point lobar CT severity score.
Results
Ground glass opacity (GGO) was the dominant finding in the early stage (89%), declining progressively to 11% in the delayed stage. Consolidation peaked in the early and progressive stages (50% each) and resolved completely by the delayed stage. Architectural distortion and reticular opacities emerged later, reaching 53% and 65% respectively in the late stage, with reticular opacities persisting at 56% in the delayed stage, indicating incomplete resolution. Vascular prominence was a consistent early marker (75% early stage). The mean CT severity score was 12.08 (range 0–25), with scores peaking at the late stage (13.05). Two novel findings were identified: fissural effusion (19 patients; 18%) and subpleural sparing (12 patients; 11%). Peripheral distribution predominated (61.9%).
Conclusion
CT manifestations of COVID-19 pneumonia demonstrate predictable stage-specific patterns. Recognition of these patterns allows accurate radiological staging, facilitates prognostication, and supports treatment decision-making. Fissural effusion and subpleural sparing are proposed as novel CT findings in COVID-19.
Zitieren
APA
Singh, S., Saroha, G. S., N., S. G., & Bhattacharjee, S. (2026). Temporal Evolution of Pulmonary Abnormalities in COVID-19 Infection: Chest CT Findings at Different Stages of Illness. International Journal of Current Pharmaceutical Review and Research, 18(05). https://doi.org/10.25258/ijcpr.18.5.28
Vancouver
Singh S, Saroha GS, N. SG, Bhattacharjee S. Temporal Evolution of Pulmonary Abnormalities in COVID-19 Infection: Chest CT Findings at Different Stages of Illness. International Journal of Current Pharmaceutical Review and Research. 2026;18(05). doi:10.25258/ijcpr.18.5.28
BibTeX
@article{Singh2026,
author = {Singh, Samarjeet and Saroha, Gulab Singh and N., Shankar Ganesh and Bhattacharjee, Saikat},
title = {Temporal Evolution of Pulmonary Abnormalities in COVID-19 Infection: Chest CT Findings at Different Stages of Illness},
journal = {International Journal of Current Pharmaceutical Review and Research},
year = {2026},
volume = {18},
number = {05},
doi = {10.25258/ijcpr.18.5.28}
}
EUVIMED